Beaumont Financial Partners, LLC Pfizer Inc Transaction History

Beaumont Financial Partners, LLC

$1.04 Billion
Q3 2022

A detailed history of Beaumont Financial Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 29,842 shares of PFE stock, worth $797,975. This represents 0.13% of its overall portfolio holdings.

Number of Shares

29,842

Previous 28,377 5.16%

Holding current value

$797,975

Previous $1.49 Million 12.23%

% of portfolio

0.13%

Previous 0.13%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $64,108 - $78,260	1,465 Added 5.16%	29,842 $1.31 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $37,642 - $44,632	-809 Reduced 2.77%	28,377 $1.49 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $139,125 - $172,394	3,041 Added 11.63%	29,186 $1.51 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $30,535 - $45,263	-739 Reduced 2.75%	26,145 $1.54 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $13,070 - $16,789	333 Added 1.25%	26,884 $1.16 Million
Q2 2021 Aug 04, 2021	SELL	$35.91 - $40.68 $14,866 - $16,841	-414 Reduced 1.54%	26,551 $1.04 Million
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $238,482 - $268,960	-7,121 Reduced 20.89%	26,965 $977,000
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $22,826 - $29,025	-682 Reduced 1.96%	34,086 $1.26 Million
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $22,637 - $26,559	713 Added 2.09%	34,768 $1.28 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $24,367 - $29,560	-809 Reduced 2.32%	34,055 $1.11 Million
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $33,841 - $48,352	-1,252 Reduced 3.47%	34,864 $1.14 Million
Q4 2019 Feb 06, 2020	BUY	$32.92 - $37.36 $213,222 - $241,980	6,477 Added 21.85%	36,116 $1.42 Million
Q3 2019 Nov 06, 2019	BUY	$32.49 - $42.13 $253,681 - $328,951	7,808 Added 35.77%	29,639 $1.01 Million
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $28,252 - $31,721	764 Added 3.63%	21,831 $946,000
Q1 2019 May 06, 2019	BUY	$37.5 - $41.2 $69,337 - $76,178	1,849 Added 9.62%	21,067 $895,000
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $43,855 - $50,000	-1,140 Reduced 5.6%	19,218 $839,000
Q2 2018 Aug 06, 2018	BUY	$32.98 - $35.16 $25,592 - $27,284	776 Added 3.96%	20,358 $739,000
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $239,931 - $278,353	7,519 Added 62.33%	19,582 $695,000
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $598 - $635	-18 Reduced 0.15%	12,063 $437,000
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $8,029 - $8,844	259 Added 2.19%	12,081 $431,000
Q2 2017 Aug 11, 2017	BUY	N/A	11,822	11,822 $397,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.

Account

Beaumont Financial Partners, LLC Pfizer Inc Transaction History